What the Independent Pharmacy Cooperative Acquisition of USave Pharmacy Group Signals

Independent Pharmacy Cooperative (IPC) has acquired USave Pharmacy Group, effective September 1,¹ in a deal that brings together two purchasing organizations that have already worked side by side for nearly a decade.

The acquisition marks the formal conclusion of a relationship that began in 2017, when IPC first partnered with the Nebraska-based group to connect USave's member pharmacies with IPC's purchasing and resource network.¹ USave has spent more than 40 years organizing independent pharmacy owners around group purchasing, peer collaboration, and advocacy.¹

It isn't IPC's first time consolidating with a fellow cooperative rather than growing store-by-store. Back in 2017, IPC merged its buying power with Pace Alliance, another leading independent-pharmacy purchasing group, in a deal Pharmaceutical Commerce described at the time as bringing together "the buying power of approximately 6,000 independent pharmacies."² Then-IPC president Don Anderson framed that combination in terms that echo this week's announcement: "IPC is continually looking for ways to bring added value to independent pharmacy."² The USave deal follows the same playbook, pooling scale while letting the acquired group keep its own identity.

For a sector where scale increasingly determines negotiating leverage with wholesalers and payers, the deal is essentially one purchasing cooperative absorbing another it has already been embedded with operationally for years. IPC has framed the move explicitly around continuity rather than integration-driven disruption: the same IPC teams that have supported USave since 2017 — member services, distribution, member performance, and government relations — will keep serving USave pharmacies going forward, with Kate Helf, IPC's vice president of pharmacy innovation and a 10-year liaison to the USave group, overseeing the transition.¹

"IPC's purpose has always been to help independent pharmacies remain strong, locally owned and positioned for the future," said Marc Essensa, IPC's president and CEO, adding that the acquisition is meant to preserve USave's identity while extending it additional resources.¹

Bill Hamik of USave Pharmacy Group struck a similar note, saying the group's pharmacies "value the relationships, responsiveness and shared identity" USave has built, and that IPC "recognizes that USave's identity is something to preserve, not replace."¹

Why Does it Matter for the Channel?

The deal lands at a moment when independent pharmacies are navigating a difficult combination of pressures on reimbursement and access. Nationally, independent community pharmacies still represent nearly 36% of all U.S. retail pharmacy locations and outnumber any single chain, but they're closing at a rate of more than one per day, according to the National Community Pharmacists Association's 2025 Digest.³

Much of that pressure traces back to PBM contracting. As Pharmaceutical Commerce has reported, three PBMs control more than 80% of U.S. prescription volume, giving them outsized leverage to set take-it-or-leave-it reimbursement terms that increasingly fall below a pharmacy's own acquisition cost for the drug.⁴ A related Pharmaceutical Commerce analysis put a sharper point on the mechanism, noting that "as PBMs have consolidated, they've used their market power to lower reimbursements" to the point that dispensing routinely pays out below acquisition cost.⁵

Purchasing cooperatives and buying groups have become one of the few levers independent, locally owned pharmacies have to offset that squeeze: pooling volume to negotiate wholesaler terms otherwise available only to larger chains or PBM-affiliated pharmacy networks. Consolidation among these cooperatives, rather than among the pharmacies themselves, is a structural response to that pressure: it lets independent owners retain their storefronts, local identity, and patient relationships while pooling purchasing volume and back-office support under a larger umbrella. IPC positions itself as a member-owned cooperative offering purchasing access, operational support, and advocacy to independent pharmacies nationally;¹ the USave acquisition extends that footprint into a group with a long-established regional base.

Neither company disclosed financial terms of the transaction.¹

References

1. IPC press release, PRNewswire. Sept. 1, 2026. https://www.prnewswire.com/news-releases/independent-pharmacy-cooperative-acquires-usave-pharmacy-group-302866725.html

2. "Leading independent pharmacy buying groups pair up." Pharmaceutical Commerce. Feb. 20, 2017. https://www.pharmaceuticalcommerce.com/view/leading-independent-pharmacy-buying-groups-pair

3. NCPA 2025 Digest release. National Community Pharmacists Association. Oct. 19, 2025. https://ncpa.org/newsroom/news-releases/2025/10/19/ncpa-releases-2025-digest-report

4. Abrams M. "The Broken Business Model Driving America's Pharmacy Deserts." Pharmaceutical Commerce. Feb. 9, 2026. https://www.pharmaceuticalcommerce.com/view/the-broken-business-model-driving-america-pharmacy-deserts

5. "Pharmacy Deserts are Becoming a National Problem." Pharmaceutical Commerce. Oct. 30, 2025. https://www.pharmaceuticalcommerce.com/view/pharmacy-deserts-becoming-national-problem